Recommendation for hormone replacement therapy in postmenopause


Authors: T. Fait 1;  J. Donát 2;  J. Jeníček 3,4;  M. Burdová 5;  J. Zahrádková 6;  P. Koliba 7
Authors‘ workplace: Gynekologicko-porodnická klinika 1. LF UK a VFN Praha, přednosta prof. MUDr. A. Martan, DrSc. 1;  Porodnicko-gynekologická klinika Pardubické krajské nemocnice, přednosta doc. M. Košťál, CSc. 2;  Centrum klimakterické medicíny, Lékařský dům Praha, a. s., vedoucí MUDr. J. Jeníček, CSc. 3;  Gynekologicko-porodnická klinika 3. LF UK a FN KV Praha, přednosta doc. MUDr. B. Svoboda, CSc. 4;  Soukromá gynekologická praxe, Praha 5;  Centrum dětských odborných zdravotních služeb Brno, o. p., ředitelka MUDr. R. Svobodová 6;  Gynartis s. r. o., vedoucí doc. MUDr. P. Koliba, CSc. 7
Published in: Ceska Gynekol 2010; 75(2): 109-110


Sources

1. Birkhauser, MH., Panay, N., Archer, DF., et al. Updated recommendations for hormone replacement therapy in the peri- and postmenopause. Climacteric 2008, 11, 2, p. 108-124.

2. Caronico, M., Plu-Bureau, G., Conard, J., et al. Hormone therapy and venous thromboembolism among postmenopausal women. Circulation 2007, 115, p. 840-845.

3. Cauley, JA., Robbins, J., Chen, Z., et al. Effects of estrogen plus progestin on risk of fracture and BMD: WHI randomized trial. JAMA 2003, 290, p. 1729-1738.

4. Collins, P., Rosano, G., Casey, C., et al. Management of cardiovascular risk in the peri-menopausal women: a consensus statement of European cardiologist and Gynaecologist. Eur Heart J 2007, 28, p. 2028-2040.

5. Čepický, P., Bendová, M., Burdová, M., a kol. Doporučení k hormonální terapii a substituci perimenopauzy a postmenopauzy. Aktualizace 2005. Čes Gynek 2006, 71, 2, s. 150-152.

6. Ettinger, B., Ensrud, KE., Wallace, R., et al. Effects of ultra low-dose transdermal estradiol on bone mineral density. Obstet Gynecol 2004, 104, p. 443-451.

7. Grodstein, F., Manson, JE., Stampfer, MJ. Hormone replacement therapy and corony heart disease: the role of time since menopause and age at hormone initiation. J Womens Health 2006, 15, p. 35-44.

8. IMS Updated recommendations on postmenopausal hormone therapy. Climacteric 2007, 10, p. 181-194.

9. Lobo, RA. Menopause and stroke and the effects of hormone terapy. Climacteric 2007, 10 (Suppl 2), p. 27-31.

10. Rossow, JE., Prentice, RL., Manson, JE., et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007, 297, p. 1465-1477.

11. Salpeter, SR., Walsh, JM., Greyber, E., et al. Mortality associated with hormone replacement therapy in younger and older women: a meta-analysis. J Gen Intern Med 2004, 19, p. 791-804.

12. Utian, WH., Archer, DF., Bachmann, GA. Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society. Menopause 2008,15, 4, p. 584-602.

Labels
Paediatric gynaecology Gynaecology and obstetrics Reproduction medicine

Article was published in

Czech Gynaecology

Issue 2

2010 Issue 2

Most read in this issue
Login
Forgotten password

Don‘t have an account?  Create new account

Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account